RHOA and autosomal dominant disease: Given that TRPV4 neuropathy mutations cause autosomal dominant disease and cause a gain of function in vivo26, we hypothesized that the co-expression of mutant TRPV4 might disrupt the normal binding of WT TRPV4 with RhoA.